Zanamivir

Zanamivir
Clinical data
Pronunciation/zəˈnæmɪvɪər/
Trade namesRelenza
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: B1
Routes of
administration		Inhalation, intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability2% (oral)
Protein binding<10%
MetabolismNegligible
Elimination half-life2.5–5.1 hours
ExcretionKidney
Identifiers
  • (2R,3R,4S)-4-guanidino-3-(prop-1-en-2-ylamino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
CompTox Dashboard (EPA)
ECHA InfoCard100.218.632 Edit this at Wikidata
Chemical and physical data
FormulaC12H20N4O7
Molar mass332.313 g·mol−1
3D model (JSmol)
  • O=C(O)C=1O[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](/N=C(\N)N)C=1
  • InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1 checkY
  • Key:ARAIBEBZBOPLMB-UFGQHTETSA-N checkY
  (verify)

Zanamivir is a medication used to treat and prevent influenza caused by influenza A and influenza B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B.[3] Zanamivir was the first neuraminidase inhibitor commercially developed. It is marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.

Properties

Zanamivir room temperature solubility in water is 36 mg/mL, in DMSO is 66 mg/mL.[4] It's insoluble in ethanol.[4]

Medical uses

Zanamivir is used for the treatment of infections caused by influenza A and influenza B viruses, but in otherwise-healthy individuals, benefits overall appear to be small. It decreases the risk of one's getting symptomatic, but not asymptomatic influenza. The combination of diagnostic uncertainty, the risk for virus strain resistance, possible side effects and financial cost outweigh the small benefits of zanamivir for the prophylaxis and treatment of healthy individuals.[5]

Since then, genes expressing resistance to zanamivir were found in Chinese people infected with avian influenza A H7N9 during treatment with zanamivir.[6]

Treatment

In otherwise-healthy individuals, benefits overall appear to be small.[5] Zanamivir shortens the duration of symptoms of influenza-like illness (unconfirmed influenza or 'the flu') by less than a day. In children with asthma there was no clear effect on the time to first alleviation of symptoms.[7] Whether it affects the risk of one's need to be hospitalized or the risk of death is not clear.[5] There is no proof that zanamivir reduced hospitalizations or pneumonia and other complications of influenza, such as bronchitis, middle ear infection, and sinusitis.[7] Zanamivir did not reduce the risk of self reported investigator mediated pneumonia or radiologically confirmed pneumonia in adults. The effect on pneumonia in children was also not significant.[8]

Prevention

Low to moderate evidence indicates it decreases the risk of one's getting influenza by 1 to 12% in those exposed.[5] Prophylaxis trials showed that zanamivir reduced the risk of symptomatic influenza in individuals and households, but there was no evidence of an effect on asymptomatic influenza or on other, influenza-like illnesses. Also there was no evidence of reduction of risk of person-to-person spread of the influenza virus.[7] The evidence for a benefit in preventing influenza is weak in children, with concerns of publication bias in the literature.[9]

Resistance

As of 2009, no influenza had shown any signs of resistance in the US.[10] A meta-analysis from 2011 found that zanamivir resistance had been rarely reported.[11] Antiviral resistance can emerge during or after treatment with antivirals in certain people (e.g., immunosuppressed).[12] In 2013 genes expressing resistance to zanamivir (and oseltamivir) were found in Chinese patients infected with avian influenza A H7N9.[6]

Adverse effects

Dosing is limited to the inhalation route. This restricts its usage, as treating asthmatics could induce bronchospasms.[13] In 2006 the Food and Drug Administration (FDA) found that breathing problems (bronchospasm), including deaths, were reported in some patients after the initial approval of Relenza. Most of these patients had asthma or chronic obstructive pulmonary disease. Relenza therefore was not recommended for treatment or prophylaxis of seasonal influenza in individuals with asthma or chronic obstructive pulmonary disease.[14] In 2009 the zanamivir package insert contains precautionary information regarding risk of bronchospasm in patients with respiratory disease.[15] GlaxoSmithKline (GSK) and FDA notified healthcare professionals of a report of the death of a patient with influenza having received zanamivir inhalation powder, which was solubilized and administered by mechanical ventilation.[16]

In adults there was no increased risk of reported adverse events in trials. There was little evidence of the possible harms associated with the treatment of children with zanamivir.[7] Zanamivir has not been known to cause toxic effects and has low systemic exposure to the human body.[17]

Mechanism of action

Zanamivir works by binding to the active site of the neuraminidase protein, rendering the influenza virus unable to escape its host cell and infect others.[18] It is also an inhibitor of influenza virus replication in vitro and in vivo. In clinical trials, zanamivir was found to reduce the time-to-symptom resolution by 1.5 days if therapy was started within 48 hours of the onset of symptoms.[citation needed]

The bioavailability of zanamivir is 2%. After inhalation, zanamivir is concentrated in the lungs and oropharynx, where up to 15% of the dose is absorbed and excreted in urine.[19]

History

Zanamivir was first made in 1989 by scientists led by Peter Colman[20][21] and Joseph Varghese[22] at the Australian CSIRO, in collaboration with the Victorian College of Pharmacy and Monash University. Zanamivir was the first of the neuraminidase inhibitors. The discovery was initially funded by the Australian biotechnology company Biota and was part of Biota's ongoing program to develop antiviral agents through rational drug design. Its strategy relied on the availability of the structure of influenza neuraminidase by X-ray crystallography. It was also known, as far back as 1974, that 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA), a sialic acid analogue, is an inhibitor of neuraminidase.[23]

Computational chemistry techniques were used to probe the active site of the enzyme, in an attempt to design derivatives of DANA that would bind tightly to the amino acid residues of the catalytic site, so would be potent and specific inhibitors of the enzyme. The GRID software by Molecular Discovery was used to determine energetically favourable interactions between various functional groups and residues in the catalytic site canyon. This investigation showed a negatively charged zone occurs in the neuraminidase active site that aligns with the C4 hydroxyl group of DANA. This hydroxyl is, therefore, replaced with a positively charged amino group; the 4-amino DANA was shown to be 100 times better as an inhibitor than DANA, owing to the formation of a salt bridge with a conserved glutamic acid (119) in the active site. Glu 119 was also noticed to be at the bottom of a conserved pocket in the active site that is just big enough to accommodate the larger, but more basic guanidine functional group.[24] Zanamivir, a transition-state analogue inhibitor of neuraminidase, was the result.[25]

In 1999, the product was approved for marketing in the US and Europe for treatment of influenza A and B. The FDA advisory committee had recommended by a vote 13 to 4 that it should not be approved, because it lacked efficacy and was no more effective than placebo when the patients were on other drugs such as paracetamol. But the FDA leadership overruled the committee and criticised its reviewer, biostatistician Michael Elashoff. The review of oseltamivir, which was also in approval process at that time, was taken away from him, and reassigned to someone else.[26] In 2006 zanamivir was approved in the US and Europe for prevention of influenza A and B.[3]

References

  1. ^ "Relenza- zanamivir powder". DailyMed. 19 October 2021. Retrieved 30 September 2022.
  2. ^ "List of nationally authorised medicinal products" (PDF). European Medicines Agency.
  3. ^ a b "FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children FDA press release March 29, 2006". FDA. Archived from the original on 6 March 2010. Retrieved 16 December 2019.
  4. ^ a b Zanamivir, 2023
  5. ^ a b c d Michiels B, Van Puyenbroeck K, Verhoeven V, Vermeire E, Coenen S (2013). "The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews". PLOS ONE. 8 (4): e60348. Bibcode:2013PLoSO...860348M. doi:10.1371/journal.pone.0060348. PMC 3614893. PMID 23565231.
  6. ^ a b Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al. (June 2013). "Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance". Lancet. 381 (9885): 2273–2279. doi:10.1016/S0140-6736(13)61125-3. PMID 23726392. S2CID 7537862.
  7. ^ a b c d Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, et al. (April 2014). "Neuraminidase inhibitors for preventing and treating influenza in adults and children". The Cochrane Database of Systematic Reviews. 2014 (4): CD008965. doi:10.1002/14651858.CD008965.pub4. PMC 6464969. PMID 24718923.
  8. ^ Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T (April 2014). "Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments". BMJ. 348 (apr09 2): g2547. doi:10.1136/bmj.g2547. PMC 3981976. PMID 24811412.
  9. ^ Wang K, Shun-Shin M, Gill P, Perera R, Harnden A (April 2012). "Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)". The Cochrane Database of Systematic Reviews. 2012 (4): CD002744. doi:10.1002/14651858.CD002744.pub4. PMC 6599832. PMID 22513907.
  10. ^ "2008-2009 Influenza Season Week 32 ending August 15, 2009". Flu Activity & Surveillance. Centers for Disease Control and Prevention (CDC). 21 August 2009.
  11. ^ Thorlund K, Awad T, Boivin G, Thabane L (May 2011). "Systematic review of influenza resistance to the neuraminidase inhibitors". BMC Infectious Diseases. 11 (1): 134. doi:10.1186/1471-2334-11-134. PMC 3123567. PMID 21592407.
  12. ^ "Influenza Antiviral Medications: Summary for Clinicians". CDC. 11 May 2018. Retrieved 21 April 2014.
  13. ^ Hayden FG (December 2001). "Perspectives on antiviral use during pandemic influenza". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 356 (1416): 1877–1884. doi:10.1098/rstb.2001.1007. PMC 1088564. PMID 11779387.
  14. ^ "FDA Approves a Second Drug for the Prevention of Influenza A and B in Adults and Children". FDA press release.
  15. ^ "Safe and Appropriate Use of Influenza Drugs". Public Health Advisories (Drugs). U.S. Food and Drug Administration (FDA). 30 April 2009. Archived from the original on 4 November 2009. Retrieved 11 November 2009.
  16. ^ "Relenza (zanamivir) Inhalation Powder". Food and Drug Administration. Archived from the original on 12 October 2009.
  17. ^ Freund B, Gravenstein S, Elliott M, Miller I (October 1999). "Zanamivir: a review of clinical safety". Drug Safety. 21 (4): 267–281. doi:10.2165/00002018-199921040-00003. PMID 10514019. S2CID 25945928.
  18. ^ Cyranoski D (September 2005). "Threat of pandemic brings flu drug back to life". Nature Medicine. 11 (9): 909. doi:10.1038/nm0905-909. PMID 16145557.
  19. ^ Moscona A (September 2005). "Neuraminidase inhibitors for influenza". The New England Journal of Medicine. 353 (13): 1363–1373. doi:10.1056/NEJMra050740. PMID 16192481. S2CID 17162678.
  20. ^ Varghese JN, Laver WG, Colman PM (1983). "Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution". Nature. 303 (5912): 35–40. Bibcode:1983Natur.303...35V. doi:10.1038/303035a0. PMID 6843658. S2CID 4363648.
  21. ^ "Colman, Peter Malcolm - CSIROpedia". Archived from the original on 4 October 2013. Retrieved 2 October 2013.
  22. ^ "Varghese, Joseph Noozhumurry - CSIROpedia". Archived from the original on 5 October 2013. Retrieved 2 October 2013.
  23. ^ Meindl P, Bodo G, Palese P, Schulman J, Tuppy H (April 1974). "Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid". Virology. 58 (2): 457–463. doi:10.1016/0042-6822(74)90080-4. PMID 4362431.
  24. ^ Laver G (1 March 2007). "Flu drugs - pathway to discovery". Education in Chemistry. Vol. 44, no. 2. Royal Society of Chemistry. pp. 48–52. ISSN 0013-1350. Retrieved 19 June 2018.
  25. ^ von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, et al. (June 1993). "Rational design of potent sialidase-based inhibitors of influenza virus replication". Nature. 363 (6428): 418–423. Bibcode:1993Natur.363..418V. doi:10.1038/363418a0. PMID 8502295. S2CID 4359333.
  26. ^ Cohen D, Carter P (June 2010). "Conflicts of interest. WHO and the pandemic flu "conspiracies"". BMJ. 340 (jun03 4): c2912. doi:10.1136/bmj.c2912. PMID 20525679. S2CID 35959611.

Read other articles:

Álvar Núñez Cabeza de Vaca

Spanish explorer of the New World Cabeza de Vaca redirects here. For other uses, see Cabeza de Vaca (disambiguation). Álvar Núñez Cabeza de VacaBust of Cabeza de VacaBornÁlvar Núñez Cabeza de Vacac. 1488/1490/1492Jerez de la FronteraDiedAfter 19 May 1559 (aged over 66–71)Jerez de la Frontera or Valladolid, SpainResting placeSpainOccupation(s)Treasurer, explorer, author of La relación y comentarios, and ex-governor of Río de Plata in ArgentinaSpouseMaría MarmolejoParent(s)Francisco ...

 

Science and technology in Uzbekistan

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: Science and technology in Uzbekistan – news · newspapers · books · scholar · JSTOR (September 201...

 

Teemu Pukki

Teemu Puki Puki bermain untuk Norwich City pada tahun 2022Informasi pribadiNama lengkap Teemu Eino Antero Puki[1]Tanggal lahir 29 Maret 1990 (umur 34)Tempat lahir Kotka, FinlandiaTinggi 180 cm (5 ft 11 in)[2]Posisi bermain PenyerangInformasi klubKlub saat ini Minnesota UnitedNomor 22Karier senior*Tahun Tim Tampil (Gol)2006–2008 KooTeePee 29 (3)2008–2009 Sevilla Atlético 17 (3)2009–2010 Sevilla 1 (0)2010–2011 HJK 25 (13)2011–2013 Schalke 04 37 (8...

Wilhelm Keitel

GeneralfeldmarschallWilhelm KeitelPotret Resmi, 1942 Panglima Oberkommando der WehrmachtMasa jabatan4 Februari 1938 – 8 Mei 1945FührerAdolf HitlerPendahuluWerner von Blomberg (sebagai Menteri Perang Reich)PenggantiAlfred JodlKepala Kantor WehrmachtamtMasa jabatan1 Oktober 1935 – 4 Februari 1938FührerAdolf HitlerMenteri ReichswehrWerner von BlombergPendahuluWalter von ReichenauPenggantiJabatan dihapus Informasi pribadiLahirWilhelm Bodewin Johann Gustav Keitel(1882-09-22...

 

Defrosting (refrigeration)

Removal of frost and ice from a refrigerator This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: Defrosting refrigeration – news · newspapers · books · scholar · JSTOR (October 2020) (Learn how and when to remove this template message) Defrosting a freezer with an improvised water collection method In refri...

 

Joanna Pettet

Cet article est une ébauche concernant une actrice britannique. Vous pouvez partager vos connaissances en l’améliorant (comment ?) selon les conventions filmographiques. Joanna PettetJoanna Pettet, 1976.BiographieNaissance 16 novembre 1942 (81 ans)LondresNationalité britanniqueFormation Neighborhood Playhouse School of the TheatreÉcole secondaire de WestmountActivités ActricePériode d'activité 1964-1990Conjoint Alan BatesAutres informationsDistinction Theatre World Award (...

Kiss (gruppo musicale)

KissI Kiss in concerto alla O2 Arena nel 2019 Paese d'origine Stati Uniti GenereHard rock[1][2][3][4]Pop metal[5][6] Periodo di attività musicale1973 – 2023 EtichettaCasablanca (1973–1982)Mercury (1982–2003)Sanctuary (2003–2008)Roadrunner-Universal (2009–2023) Album pubblicati44 Studio20 Live7 Raccolte17 Logo ufficiale Sito ufficiale Modifica dati su Wikidata · Manuale I Kiss (spesso reso graficament...

 

Casino (cocktail)

Cocktail CasinoIBA official cocktailCasinoTypeCocktailBase spirit Gin ServedStraight up: chilled, without iceStandard garnishLemon twist and maraschino cherryStandard drinkware Cocktail glassIBA specifiedingredients† 4 cl gin (Old Tom) 1 cl Maraschino 1 cl fresh lemon juice 2 dashes orange bitters PreparationPour all ingredients into shaker with ice cubes. Shake well. Strain into chilled cocktail glass. Garnish with a lemon twist and a maraschino cherry. Serve without a straw.Commonly serve...

 

Oberon (poem)

German epic poem Title page of the first edition, without the author's name. Oberon is an epic poem by the German writer Christoph Martin Wieland. It was based on the epic romance Huon de Bordeaux, a French medieval tale,[1] and influenced by Shakespeare's A Midsummer Night's Dream and Alexander Pope's version of Geoffrey Chaucer's The Merchant's Tale.[2] It first appeared in 1780 and went through seven rewrites before its final form was published in 1796. Plot For the slaying...

Everybody Go Home

1960 Italian filmEverybody Go HomeDirected byLuigi ComenciniWritten byAge & ScarpelliLuigi ComenciniMarcello FondatoProduced byDino De LaurentiisStarringAlberto SordiEduardo De FilippoSerge ReggianiMartin BalsamNino CastelnuovoClaudio GoraCarla GravinaCinematographyCarlo CarliniEdited byGiovannino BaragliMusic byAngelo Francesco LavagninoRelease date 27 October 1960 (1960-10-27) Running time120 minutesCountryItalyLanguageItalian Everybody Go Home (Italian: Tutti a casa) is ...

 

Swing (Java)

Java-based GUI toolkit Example Swing widgets in Java Swing is a GUI widget toolkit for Java.[1] It is part of Oracle's Java Foundation Classes (JFC) – an API for providing a graphical user interface (GUI) for Java programs. Swing was developed to provide a more sophisticated set of GUI components than the earlier Abstract Window Toolkit (AWT). Swing provides a look and feel that emulates the look and feel of several platforms, and also supports a pluggable look and feel tha...

 

Sinkyone Wilderness State Park

State park in Humboldt and Mendocino Counties, California, United States Sinkyone Wilderness State ParkBear HarborShow map of CaliforniaShow map of the United StatesLocationMendocino County, CaliforniaNearest cityLeggett, CaliforniaCoordinates39°55′N 123°56′W / 39.92°N 123.94°W / 39.92; -123.94OperatorCalifornia Department of Parks and Recreation Sinkyone Wilderness State Park is a state park in Mendocino County, California. The wilderness area borders the...

Hanseatic League

1200s–1669 trade confederation in Northern Europe This article is about the 13th to 17th century trade association. For the modern business association, see Hanseatic Parliament. For the intra-EU political group, see New Hanseatic League. This article may require copy editing for grammar, style, cohesion, tone, or spelling. You can assist by editing it. (April 2023) (Learn how and when to remove this message) Hanseatic LeagueHanseHansa Hanseatic pennantNorthern Europe in the 1400s, showing ...

 

Clare Boothe Luce

Clare Boothe Luce Ambasciatore in ItaliaDurata mandato4 maggio 1953 - 27 aprile 1956 PredecessoreEllsworth Bunker SuccessoreJames David Zellerbach Membro della Camera dei Rappresentanti - Connecticut, distretto n.4Durata mandato3 gennaio 1943 - 3 gennaio 1947 PredecessoreLe Roy D. Downs SuccessoreJohn D. Lodge Dati generaliPartito politicoRepubblicano Professionegiornalista, diplomatica Clare Boothe Luce (nata Ann Clare Boothe; New York, 10 marzo 1903 – Washington, 9 ottobre ...

 

Kuwait ai Giochi della XX Olimpiade

Kuwait ai Giochi della XX OlimpiadeMonaco di Baviera 1972 Codice CIOKUW Comitato nazionaleComitato Olimpico del Kuwait Atleti partecipanti4 in 2 discipline Di cui uomini/donne4 - 0 PortabandieraYounis Abdallah Medagliere Posizione - 0 0 0 0 Cronologia olimpica (sommario)Giochi olimpici estivi 1968 · 1972 · 1976 · 1980 · 1984 · 1988 · 1992 · 1996 · 2000 · 2004 · 2008 · 2012 · 2016 · 2020 Giochi oli...

Silangkitang Tambiski, Saipar Dolok Hole, Tapanuli Selatan

Silangkitang TambiskiDesaPeta lokasi Desa Silangkitang TambiskiNegara IndonesiaProvinsiSumatera UtaraKabupatenTapanuli SelatanKecamatanSaipar Dolok HoleKode pos22758Kode Kemendagri12.03.05.2078 Luas11,13 km2Jumlah penduduk435 (2012)Kepadatan39,09 jiwa/km2 Silangkitang Tambiski adalah salah satu desa yang berada di Kecamatan Saipar Dolok Hole, Kabupaten Tapanuli Selatan, Provinsi Sumatera Utara, Indonesia. Desa ini dibentuk pada tahun 2008 sebagai hasil penggabungan desa Batu Hombang, Say...

 

Vlăhița

Vlăhița SzentegyházaKotaLetak VlăhiţaNegaray RumaniaCountyCounty HarghitaStatusKotaPemerintahan • Wali kotaRus Sándor (Independen)Luas • Total98,48 km2 (3,802 sq mi)Populasi (2011) • Total6.820Etnis • Hungaria98.3% • Rumania1.7%Zona waktuUTC+2 (EET) • Musim panas (DST)UTC+3 (EEST)Situs webhttp://www.primariavlahita.ro/ro/index.php Vlăhița (bahasa Hungaria: Szentegyháza, pengucapan bah...

 

Fox

Genera of mammal This article is about the animal. For the American television network, see Fox Broadcasting Company. For other uses, see Fox (disambiguation). Foxes, Vixen, and Skulk redirect here. For other uses, see Foxes (disambiguation), Vixen (disambiguation), and Skulk (disambiguation). Foxes A red fox in Algonquin Provincial Park, Ontario Scientific classification Domain: Eukaryota Kingdom: Animalia Phylum: Chordata Class: Mammalia Order: Carnivora Family: Canidae Subfamily: Caninae G...

U.S. Route 83

Questa voce sull'argomento strade degli Stati Uniti d'America è solo un abbozzo. Contribuisci a migliorarla secondo le convenzioni di Wikipedia. U.S. Route 83LocalizzazioneStato Stati Uniti DatiClassificazioneAutostrada InizioWesthope (Dakota del Nord) FineBrownsville (Texas) Lunghezza3.048 km DirezioneNord-sud Data apertura1926 PercorsoPrincipali intersezioniManitoba Highway 83 a Westhope (ND) Interstate 94 da Bismarck (ND) a Sterling (ND) U.S. Route 14 a Pierre (SD) Interstate 9...

 

新潟工業短期大学

新潟工業短期大学 新潟工業短期大学大学設置 1968年創立 1962年学校種別 私立設置者 学校法人新潟科学技術学園本部所在地 新潟県新潟市西区上新栄町5丁目13番7号学部 自動車工業科[注 1]研究科 自動車工学専攻[注 2]ウェブサイト http://www.niigata-ct.ac.jp/テンプレートを表示 新潟工業短期大学（にいがたこうぎょうたんきだいがく、英語: Niigata College of Technology�...